PHVS.NASDAQPharvaris NV

Form 4: Pharvaris CMO Peng Lu Reports Stock Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Medical Officer Peng Lu reported the withholding of 226 shares of Pharvaris N.V. common stock to satisfy tax obligations.

Summary

  • Peng Lu, Chief Medical Officer of Pharvaris N.V., executed a transaction involving the withholding of 226 shares of common stock.
  • The transaction occurred on April 16, 2026, at a price of $28.78 per share.
  • The withholding was conducted to satisfy tax obligations related to the vesting of restricted stock units on April 11 and April 12, 2026.
  • Following this transaction, Peng Lu maintains beneficial ownership of 66,083 shares of Pharvaris common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative action regarding executive tax obligations rather than a discretionary trade.

Positives

  • The transaction reflects the vesting of equity compensation, indicating ongoing alignment between executive incentives and company performance.

Negatives

  • None identified; this is a routine administrative transaction related to tax obligations.

Risks

  • None identified; this is a standard regulatory disclosure of a tax-related share withholding.

Future Outlook

Not applicable; this is a retrospective disclosure of a completed transaction.

Industry Context

StockSavvy.ai notes that routine tax-related share withholdings by executives are standard industry practice and do not typically signal changes in management sentiment or strategic direction.

Comparison to Industry Standards

  • The transaction follows standard SEC reporting requirements for executive equity compensation.
  • The practice of withholding shares to cover tax liabilities upon vesting is consistent with common corporate governance practices in the biotechnology sector.

Stakeholder Impact

  • Minimal impact on shareholders as the transaction is a standard tax-related withholding.

Next Steps

  • None identified.

Key Dates

DateDescription
04/11/2026Vesting date of restricted stock units.
04/12/2026Vesting date of restricted stock units.
04/16/2026Transaction date for tax withholding.
04/20/2026Filing date of the Form 4.

Keywords

Pharvaris, PHVS, Insider Trading, Form 4, Chief Medical Officer, Equity Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.